Search
Treatment
Applying interventions designed to reduce and manage the symptoms of substance use disorders.
Nabiximols Combined with Motivational Enhancement/Cognitive Behavioral Therapy for the Treatment of Cannabis Dependence
Abstract
Background
The current lack of pharmacological treatments for cannabis use disorder (CUD) warrants novel approaches and further investigation of promising pharmacotherapy. We previously showed that nabiximols (27 mg/ml Δ9...
Measuring Treatment Outcomes in Gambling Disorders
Abstract
Background and Aims
Considerable variation of outcome variables used to measure recovery in the gambling treatment literature has precluded effective cross-study evaluations and hindered the development of best-practice treatment...
Contemporary Routes of Cannabis Consumption: A Primer for Clinicians
Abstract
Although cannabis use is federally prohibited, medical cannabis is legal in some form in 30 states and the District of Columbia, and recreational use is legal in 8 states and the District of Columbia. The increasing legal...
Reported Theory Use by Digital Interventions for Hazardous and Harmful Alcohol Consumption, and Association with Effectiveness
ABSTRACT
Background: Applying theory to the design and evaluation of interventions is likely to increase effectiveness and improve the evidence base from which future interventions are developed, though few interventions report this.
Obje...
Effectiveness Bank Matrix Cell: Can Medications Make It *Too* Easy to Recover?
Drug-based treatments dominate opiate addiction treatment but are far from universally accepted. Referring to chemical ‘solutions’ to addiction, the ‘bite’ commentary on this cell ends with the “curious possibility that precisely because a...
Intervention guide mhGAP for mental, neurological disorders and substance use in the level of non-specialized health care. Version 2.0
Mental, neurological and substance (MNS) disorders are very common and represent a large burden of disease and disability around the world. There remains a wide gap between the capacity of health systems and resources, between what is...
mhGAP Intervention Guide - Version 2.0 for Mental, Neurological and Substance Use Disorders in Non-Specialized Health Settings
Overview
This is the second version (2016) of the mhGAP Intervention Guide (mhGAP-IG) for mental, neurological and substance use (MNS) disorders in non-specialist health settings. It is for use by doctors, nurses, other health workers as...
Women and drug treatment
Guide to clinical advice for treatment and rehabilitation programs in drugs in specific population of adult women.
Are you an ISSUP member? If not, you can join ISSUP by registering here: https://www.issup.net/membership/apply
Are a part...
Certification of Addiction Professionals in Africa: An Overview of the Process in Kenya
Abstract
This paper focuses on Kenya’s course of action to address the drug problem, specifically, treatment and rehabilitation of persons with Substance Use Disorders (SUDs). Treatment and rehabilitation of persons with SUDs was formally...
Supervised Dosing with a Long-Acting Opioid Medication in the Management of Opioid Dependence
Trials challenge the need for the widely accepted policy of making opioid-dependent patients take their methadone or other opioid substitutes at the clinic or pharmacy, but ‘no difference’ findings may be due to the limitations of the...
Recommendations for NIDA's Cannabis Policy Research Agenda
The National Institute on Drug Abuse (NIDA) has released a new report Recommendations for NIDA's Cannabis Policy Research Agenda.
The document has been prepared by the National Advisory Council on Drug Abuse Workgroup which was formed in...
The Winding Road to Relapse: Forging a New Understanding of Cue-Induced Reinstatement Models and their Associated Neural Mechanisms
In drug addiction, cues previously associated with drug use can produce craving and frequently trigger the resumption of drug taking in individuals vulnerable to relapse. Environmental stimuli associated with drugs or natural reinforcers...
Alcohol and Drugs Prevention, Treatment and Recovery: Why Invest?
Estimates show that in the UK the social and economic costs of alcohol related harm amount to £21.5bn, while harm from illicit drug use costs £10.7bn. These include costs associated with deaths, the NHS, crime and, in the case of alcohol...
A Pocket Guide: investigation of the abuse of alcohol and a brief intervention
This Pocket Guide was summarized Guide 34 pages of the NIAAA, helping patients who drink too much: A guide clinical. Materials include:
- Educational brochures for patients
- Already formatted progress notes
- Animated slideshow for...
Guide for health care professionals - helping patients who drink too much
Guide aimed at professionals of health to work with people from drinking alcohol in excess
This guide has been written for primary care health and mental health professionals. It has been produced by the National Institute on the Alcohol...
Dual Disorders in Individuals under Treatment for both Alcohol and Cocaine
Abstract
Introduction: Descriptive data about co-occurrence of alcohol and cocaine consumption is scarce, despite its important prevalence. Dual disorders show high prevalence in clinical samples, and patients report worse evolution and...
Mentor Launches Quality Mark for Alcohol and Drugs Education
Mentor UK, an organisation focused on drug prevention and education, have launched a Quality Mark for alcohol and drugs education.
The quality mark has been developed in addition to a set of developmental quality standards for schools and...
Self-Reported Knowledge, Correct Knowledge and Use of UK Drinking Guidelines among a Representative Sample of the English Population
Researchers from the University of Sheffield have investigated UK drinker's decision making. This research examines public knowledge and use of UK drinking guidelines exploring a representative sample of the English population.
Published...
The International Model of Alcohol Harms and Policies
The Canadian Institute for Substance Use Research at the University of Victoria have released The International Model of Alcohol Harms and Policies.
Comprising of a set of guidelines, methods, and tools this resource was produced with the...
Estimating Treatment Coverage for People with Substance Use Disorders: An Analysis of Data from the World Mental Health Surveys
Abstract
Substance use is a major cause of disability globally. This has been recognized in the recent United Nations Sustainable Development Goals (SDGs), in which treatment coverage for substance use disorders is identified as one of the...
Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member